Robert W. Ashworth
Conseiller Juridique Général chez ATYR PHARMA, INC.
Postes actifs de Robert W. Ashworth
Sociétés | Poste | Début | Fin |
---|---|---|---|
ATYR PHARMA, INC. | Conseiller Juridique Général | 06/10/2021 | - |
Historique de carrière de Robert W. Ashworth
Anciens postes connus de Robert W. Ashworth
Sociétés | Poste | Début | Fin |
---|---|---|---|
ONCOSEC MEDICAL INCORPORATED | Conseiller Juridique Général | 30/07/2018 | - |
Corporate Officer/Principal | - | 01/09/2021 | |
AYALA PHARMACEUTICALS, INC. | Compliance Officer | 01/01/2015 | 01/01/2018 |
Conseiller Juridique Général | 01/01/2015 | 01/01/2018 | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Conseiller Juridique Général | - | - |
NPS PHARMACEUTICALS, INC. | Conseiller Juridique Général | - | - |
Formation de Robert W. Ashworth
Massachusetts Institute of Technology | Doctorate Degree |
St. John's University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
General Counsel | 5 |
Compliance Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ONCOSEC MEDICAL INCORPORATED | Health Services |
ATYR PHARMA, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
- Bourse
- Insiders
- Robert W. Ashworth
- Expérience